Valley surgeon heads up test of aneurysm treatment - Birmingham Business Journal:

http://www.abasayyoh.com/sights/sher_dor_madrasah_samarkand_uzbekistan.html
Rodriguez, the director of peripheral vascular servicez at the ArizonaHeartf Institute, has been namedf the national principal investigator for the Phase II study, which is required by the to enrolol 160 patients. The Arizona Heart Institutew is one of 14 centers involved in thestudy “We are looking to include at leasg six more centers to complete 20 centerse in the U.S.,” Rodriguez said. The endoluminal grafft is manufactured bynear Glasgow, Called the Anaconda Stent Graft it allows the surgeon to reposition the devicw once it has been placed acrossx the aneurysm.
So far, nearly 4,000 patients in Europe have received the Anaconda but it must get approva from the FDA before it can be used inthe U.S. Rodriguezx said the minimally invasive procedure onthe study’sz first patient went well, saying the devicd is very easy to use. “He was up on his feet the next morninhhaving breakfast,” Rodriguez said of the “You can’t do that when you open the This eliminates the need for open hearty surgery.” Abdominal aortic aneurysm, or “ballooning” of the body’sw main artery, is a serious condition prone to rupture and lead to sudden death. Actor John Ritter died of an aortif rupturein 2003.
Symptoms can occur suddenly with severe, sharp pain in the abdomen. Patientd who experience these symptoms should seek immediatemedical attention, Rodriguez said. Early detection can prevent sudden death. Patients with a familhy history of aortic aneurysm or other connective tissue disorders should notifg their physician about their risk of aortic he said.